JOINT HTA- THE NEXT STEP FOR THE ASEAN ECONOMIC COMMUNITY?
Author(s)
Gengshi Chen, BA, MSci, MSc, Costello Medical Singapore Pte Ltd, Singapore, Singapore; Surachat Ngorsuraches, PhD, Prince of Songkla University, Songkhla, Thailand; Ken Redekop, PhD, Erasmus University Rotterdam, Rotterdam, The Netherlands
Presentation Documents
ISSUE: Application of health technology assessments (HTA) to support resource allocation decisions can improve efficiency of healthcare systems. However, most of the countries in ASEAN currently have limited human and financial resources for full-scale HTA implementation.
OVERVIEW: One solution for overcoming the low availability of HTA expertise in ASEAN could be to establish a joint HTA body, which could provide support to individual countries, akin to EUnetHTA in Europe. We will discuss the feasibility, opportunities and challenges for a joint HTA body in ASEAN. A number of initiatives have already been established in Asia, with the objective of promoting the development of HTA capacity and collaboration in HTA activities between member states, including the HTAsiaLink network, and the Asia Pacific Regional Capacity Building for HTA (ARCH) initiative. Given the comparable levels of economic development in many of the ASEAN member states, a joint HTA body could be considered in order to concentrate HTA capacity and accelerate evidence development, whilst reducing duplicative efforts and improving the overall efficiency of HTA. A similar rationale led to the establishment of EUnetHTA, which has provided a platform for collaboration across member states and speed-up decision making in countries with less well-established national HTA processes. However, the diversity of healthcare systems, legal frameworks, and existing HTA capacity in ASEAN, may limit the success of such an undertaking, as well as delay HTA capacity building within individual countries. Other concerns associated with joint HTA initiatives include encroachment upon national autonomy in decision making, delays due to need for national adaptation of joint HTA evidence, quality of HTA evidence developed, generalisability of joint HTA evidence to national settings, and willingness to contribute to the joint HTA effort. The panellists will present their view points from different perspectives, following which the audience will be invited to participate in the debate.
Conference/Value in Health Info
2016-09, ISPOR Asia Pacific 2016, Singapore
Code
IP3
Topic
Health Technology Assessment, Organizational Practices